Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Material agreement · Regulation FD disclosure · Other events
  3. 8-K/A Event Other events
  4. 8-K Event Results of operations
  5. 10-Q Report Quarterly Report
  6. 8-K Event Regulation FD disclosure
  7. 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  8. 8-K Event Results of operations
  9. 10-Q Report Quarterly Report
  10. 8-K Event Unregistered share sale
  11. 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
  12. 10-K/A Report 10-K/A
  13. 8-K Event Results of operations
  14. 10-K Report Annual Report
  15. 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Code of ethics change
  16. 8-K Event Delisting notice
  17. 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
  18. 8-K Event Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  19. 8-K Event Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  20. 8-K Event Other events

Page 3 of 12 · 221 filings